|
GB1144905A
(en)
|
1965-03-25 |
1969-03-12 |
Fisons Pharmaceuticals Ltd |
Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof
|
|
US3686412A
(en)
|
1965-03-25 |
1972-08-22 |
Colin Fitzmaurice |
Compositions containing bis-chromonyl compounds for inhibiting antigen-antibody reactions
|
|
US3957965A
(en)
|
1967-08-08 |
1976-05-18 |
Fisons Limited |
Sodium chromoglycate inhalation medicament
|
|
GB1242211A
(en)
|
1967-08-08 |
1971-08-11 |
Fisons Pharmaceuticals Ltd |
Pharmaceutical composition
|
|
GB1257162A
(enExample)
|
1968-02-16 |
1971-12-15 |
|
|
|
US4405598A
(en)
|
1976-01-30 |
1983-09-20 |
Fisons, Limited |
Composition for treating asthma
|
|
DE3104294A1
(de)
|
1981-02-07 |
1982-08-19 |
Hoechst Ag, 6000 Frankfurt |
Substituierte diazaspirodecane, ihre herstellung, ihre verwendung als stabilisatoren fuer organische polymere, sowie die so stabilisierten polymeren
|
|
US4429545A
(en)
|
1981-08-03 |
1984-02-07 |
Ocean & Atmospheric Science, Inc. |
Solar heating system
|
|
BE897058A
(fr)
|
1982-06-25 |
1983-12-16 |
Sandoz Sa |
Utilisation d'un derive du spiro-succinimide dans le traitement de la demence du type alzheimer
|
|
US4996296A
(en)
|
1983-07-27 |
1991-02-26 |
Yeda Research & Development Co., Ltd. |
Cromolyn binding protein in highly purifed form, and methods for the isolation thereof
|
|
US4919915A
(en)
|
1987-03-03 |
1990-04-24 |
Paul Averback |
Method for detecting the ability to prevent red-to-green congophilic birefringence
|
|
US5231170A
(en)
|
1986-08-27 |
1993-07-27 |
Paul Averback |
Antibodies to dense microspheres
|
|
DE69027319T2
(de)
|
1989-04-28 |
1996-11-21 |
Riker Laboratories Inc., Northridge, Calif. |
Inhalationsvorrichtung für trockenpulver
|
|
US5376386A
(en)
|
1990-01-24 |
1994-12-27 |
British Technology Group Limited |
Aerosol carriers
|
|
DE4405387A1
(de)
|
1994-02-19 |
1995-08-24 |
Hoechst Ag |
Verfahren zur Herstellung von Polyalkyl-1-oxa-diazaspirodecan-Verbindungen
|
|
US6168776B1
(en)
|
1994-07-19 |
2001-01-02 |
University Of Pittsburgh |
Alkyl, alkenyl and alkynyl Chrysamine G derivatives for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
|
|
CA2174583A1
(en)
|
1995-05-05 |
1996-11-06 |
Alexander Chucholowski |
Sulfuric acid esters of sugar alcohols
|
|
US6026809A
(en)
|
1996-01-25 |
2000-02-22 |
Microdose Technologies, Inc. |
Inhalation device
|
|
US6126919A
(en)
|
1997-02-07 |
2000-10-03 |
3M Innovative Properties Company |
Biocompatible compounds for pharmaceutical drug delivery systems
|
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
|
AU750567B2
(en)
|
1997-09-29 |
2002-07-25 |
Novartis Ag |
Stabilized preparations for use in nebulizers
|
|
US6309623B1
(en)
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
|
US5904937A
(en)
|
1997-10-03 |
1999-05-18 |
Fmc Corporation |
Taste masked pharmaceutical compositions
|
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
|
CN1623607B
(zh)
|
1998-06-12 |
2011-03-30 |
微量技术公司 |
用于从容器输送粉状药物的空气吸入装置
|
|
US6197963B1
(en)
|
1998-08-13 |
2001-03-06 |
The Trustees Of The University Of Pennsylvania |
Non-peptide peptidomimetics
|
|
DK1131059T3
(da)
|
1998-11-13 |
2003-06-30 |
Jago Res Ag |
Tørpulver til inhalation
|
|
HUP0104778A3
(en)
|
1998-12-24 |
2004-05-28 |
Janssen Pharmaceutica Nv |
Controlled release galantamine composition
|
|
JP2001151673A
(ja)
|
1999-09-06 |
2001-06-05 |
Nikken Chem Co Ltd |
吸入用粉末製剤の製造方法
|
|
US20020107173A1
(en)
|
1999-11-04 |
2002-08-08 |
Lawrence Friedhoff |
Method of treating amyloid beta precursor disorders
|
|
US20020009491A1
(en)
|
2000-02-14 |
2002-01-24 |
Rothbard Jonathan B. |
Compositions and methods for enhancing drug delivery across biological membranes and tissues
|
|
ES2248283T3
(es)
|
2000-02-21 |
2006-03-16 |
Pharmexa A/S |
Nuevo procedimiento para reducir los niveles de amiloide.
|
|
AU5702201A
(en)
|
2000-04-13 |
2001-10-30 |
Mayo Foundation |
Abeta<sub>42</sub> lowering agents
|
|
US20080021085A1
(en)
|
2000-04-13 |
2008-01-24 |
Mayo Foundation For Medical Education And Research |
Method of reducing abeta42 and treating diseases
|
|
PE20011227A1
(es)
|
2000-04-17 |
2002-01-07 |
Chiesi Farma Spa |
Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
|
|
AR035642A1
(es)
|
2000-05-26 |
2004-06-23 |
Pharmacia Corp |
Uso de una composicion de celecoxib para el alivio rapido del dolor
|
|
US20020016359A1
(en)
|
2000-06-29 |
2002-02-07 |
Hellberg Mark R. |
Compositions and methods of treating neurodegenerative diseases
|
|
US8519005B2
(en)
|
2000-07-27 |
2013-08-27 |
Thomas N. Thomas |
Compositions and methods to prevent toxicity of antiinflammatory agents and enhance their efficacy
|
|
FR2815030A1
(fr)
|
2000-10-05 |
2002-04-12 |
Lipha |
Derives nitroso de la diphenylamine, compositions pharmaceutiques les contenant et leur utilisation pour la preparation de medicaments
|
|
US6511960B2
(en)
|
2001-01-05 |
2003-01-28 |
Alphamed Pharmaceuticals Corp |
Cromolyn for eye and ear infections
|
|
CN100422180C
(zh)
|
2001-04-23 |
2008-10-01 |
宾夕法尼亚州大学理事会 |
淀粉样斑块聚集抑制剂和诊断成像剂
|
|
US20040259952A1
(en)
|
2001-11-29 |
2004-12-23 |
Richat Abbas |
Formulations for oral administration of cromolyn sodium
|
|
PT1521609E
(pt)
|
2002-05-10 |
2010-03-03 |
Oriel Therapeutics Inc |
Inalador de pó seco para utilização com meios de distribuição accionados por um polímero piezoeléctrico e embalagem blister associada compreendendo um material polimérico piezoeléctrico
|
|
US20060276455A1
(en)
|
2003-02-13 |
2006-12-07 |
Lindsberg Perttu J |
Use of a mast cell activation or degranulation blocking agent in the manufacture of a medicament for the treatment of cerebral ischemia
|
|
EP1601379A1
(en)
*
|
2003-02-13 |
2005-12-07 |
Licentia OY |
Use of a mast cell activation or degranulation blocking agent in the manufacture of a medicament for the treatment of a patient subjected to thrombolyses
|
|
US20040223918A1
(en)
|
2003-05-07 |
2004-11-11 |
Chrysalis Technologies Incorporated |
Aerosolization of cromolyn sodium using a capillary aerosol generator
|
|
GB0321607D0
(en)
|
2003-09-15 |
2003-10-15 |
Vectura Ltd |
Manufacture of pharmaceutical compositions
|
|
JP2007509941A
(ja)
|
2003-10-28 |
2007-04-19 |
グラクソ グループ リミテッド |
ラクトース無水物を用いる吸入医薬製剤およびその投与方法
|
|
GB0326632D0
(en)
|
2003-11-14 |
2003-12-17 |
Jagotec Ag |
Dry powder formulations
|
|
DE10355559A1
(de)
|
2003-11-21 |
2005-06-23 |
Orthogen Ag |
Transskin
|
|
US8088935B2
(en)
|
2003-12-23 |
2012-01-03 |
Ironwood Pharmaceuticals, Inc. |
Compounds and methods for the treatment of asthma
|
|
WO2005077394A1
(en)
|
2004-02-11 |
2005-08-25 |
Ramot At Tel-Aviv University Ltd |
Compositions for treatment of cancer and inflammation with curcumin and at least one nsaid
|
|
US20050182044A1
(en)
|
2004-02-17 |
2005-08-18 |
Bruinsma Gosse B. |
Combinatorial therapy with an acetylcholinesterase inhibitor and (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate
|
|
WO2006001877A2
(en)
|
2004-04-13 |
2006-01-05 |
Myriad Genetics, Inc. |
Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
|
|
EP2708225B1
(en)
|
2004-04-23 |
2018-12-26 |
CyDex Pharmaceuticals, Inc. |
DPI Formulation Containing Sulfoalkyl Ether Cyclodextrin
|
|
CA2577268A1
(en)
|
2004-08-30 |
2006-03-09 |
Seo Hong Yoo |
Neuroprotective effect of solubilized udca in focal ischemic model
|
|
CA2585471A1
(en)
*
|
2004-11-01 |
2006-05-11 |
Seo Hong Yoo |
Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis
|
|
GB0426146D0
(en)
|
2004-11-29 |
2004-12-29 |
Bioxell Spa |
Therapeutic peptides and method
|
|
KR20070122497A
(ko)
|
2005-04-22 |
2007-12-31 |
제넨테크, 인크. |
Ｃｄ20 항체로 치매 또는 알츠하이머병을 치료하는 방법
|
|
CA2609980C
(en)
|
2005-05-27 |
2015-10-13 |
Queen's University At Kingston |
Treatment of protein folding disorders
|
|
CA2631493A1
(en)
|
2005-12-15 |
2007-06-21 |
Acusphere, Inc. |
Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration
|
|
US8263645B2
(en)
|
2006-02-03 |
2012-09-11 |
Pari Pharma Gmbh |
Disodium cromoglycate compositions and methods for administering same
|
|
AR059356A1
(es)
|
2006-02-14 |
2008-03-26 |
Astrazeneca Ab |
Nuevos radioligandos
|
|
US7700618B2
(en)
|
2006-03-06 |
2010-04-20 |
Pfizer Inc |
Sulfonyl benzimidazole derivatives
|
|
EP1996175A4
(en)
|
2006-03-09 |
2009-06-10 |
Waratah Pharmaceuticals Inc |
CYCLOHEXAN POLYALKOHOL FORMULATION FOR THE TREATMENT OF PROTEIN AGGREGATION DISORDERS
|
|
US7700616B2
(en)
|
2006-05-08 |
2010-04-20 |
Molecular Neuroimaging, Llc. |
Compounds and amyloid probes thereof for therapeutic and imaging uses
|
|
US8445437B2
(en)
|
2006-07-27 |
2013-05-21 |
The Brigham And Women's Hospital, Inc. |
Treatment and prevention of cardiovascular disease using mast cell stabilizers
|
|
US20100173960A1
(en)
|
2006-09-21 |
2010-07-08 |
Antonio Cruz |
The Combination of a Cyclohexanehexol and a NSAID for the Treatment of Neurodegenerative Diseases
|
|
EP2091566A4
(en)
|
2006-11-24 |
2011-07-06 |
Waratah Pharmaceuticals Inc |
COMBINATION THERAPIES AGAINST ALZHEIMER DISEASE AND SIMILAR ILLNESSES
|
|
WO2008128981A1
(en)
|
2007-04-18 |
2008-10-30 |
Probiodrug Ag |
Nitrovinyl-diamine derivatives as glutaminyl cyclase inhibitors
|
|
US20080292625A1
(en)
|
2007-04-18 |
2008-11-27 |
Sally Schroeter |
Prevention and treatment of cerebral amyloid angiopathy
|
|
US7858803B2
(en)
|
2007-04-27 |
2010-12-28 |
The General Hospital Corporation |
Imaging tracers for early detection and treatment of amyloid plaques caused by Alzheimer's disease and related disorders
|
|
CA2693771A1
(en)
|
2007-07-13 |
2009-01-22 |
Abbott Biotechnology Ltd. |
Methods and compositions for pulmonary administration of a tnf.alpha. inhibitor
|
|
GB0714134D0
(en)
|
2007-07-19 |
2007-08-29 |
Norton Healthcare Ltd |
Dry-powder medicament
|
|
SI2182983T1
(sl)
|
2007-07-27 |
2014-09-30 |
Janssen Alzheimer Immunotherapy |
Zdravljenje amiloidogenih bolezni s humaniziranimi protitelesi proti abeta
|
|
JO3076B1
(ar)
|
2007-10-17 |
2017-03-15 |
Janssen Alzheimer Immunotherap |
نظم العلاج المناعي المعتمد على حالة apoe
|
|
JP5501339B2
(ja)
|
2008-03-21 |
2014-05-21 |
ザ ジェネラル ホスピタル コーポレイション |
アルツハイマー病及び関連疾患の検出及び治療のための化合物及び組成物
|
|
BRPI0911874A2
(pt)
|
2008-04-29 |
2018-05-22 |
Pharnext |
composições combinadas para o tratamento da doença de alzheimer e doenças relacionadas com zonisamida e acamprosato
|
|
JP5816883B2
(ja)
|
2009-01-22 |
2015-11-18 |
ラクオリア創薬株式会社 |
Ｃｂ２受容体作動活性を有するｎ−置換飽和ヘテロ環スルホン化合物
|
|
US8381454B1
(en)
|
2009-01-23 |
2013-02-26 |
Markus R. Robinson |
Segmented, elongated, expandable, 4-season, double-walled, low-cost, rigid extruded plastic panel structures
|
|
US9925282B2
(en)
|
2009-01-29 |
2018-03-27 |
The General Hospital Corporation |
Cromolyn derivatives and related methods of imaging and treatment
|
|
US8617517B2
(en)
|
2009-01-29 |
2013-12-31 |
The General Hospital Corporation |
Cromolyn derivatives and related methods of imaging and treatment
|
|
TW201613969A
(en)
|
2009-03-05 |
2016-04-16 |
Abbvie Inc |
IL-17 binding proteins
|
|
US8129404B2
(en)
|
2009-03-11 |
2012-03-06 |
Plexxikon Inc. |
Compounds and uses thereof
|
|
US8377947B2
(en)
|
2009-03-16 |
2013-02-19 |
Chien-Hung Chen |
Treating alzheimer's disease and osteoporosis and reducing aging
|
|
PL2248517T3
(pl)
|
2009-05-08 |
2014-08-29 |
Pari Pharma Gmbh |
Stężone formulacje farmaceutyczne stabilizujące komórki tuczne
|
|
AU2010281524A1
(en)
*
|
2009-08-06 |
2012-02-23 |
Neuraltus Pharmaceuticals, Inc. |
Treatment of macrophage-related disorders
|
|
MX2012003083A
(es)
|
2009-09-24 |
2012-04-30 |
Wista Lab Ltd |
Clorhidratos de metiltioninio (azul de metileno) cristalinos.
|
|
EP2322163A1
(en)
|
2009-11-03 |
2011-05-18 |
Pharnext |
New therapeutics approaches for treating alzheimer disease
|
|
US20110262442A1
(en)
|
2009-11-06 |
2011-10-27 |
Adenios, Inc. |
Compositions for treating cns disorders
|
|
MX337603B
(es)
|
2009-11-30 |
2016-03-10 |
Adare Pharmaceuticals Inc |
Composiciones y tabletas farmaceuticas con recubrimiento compresible y metodos de fabricacion.
|
|
US20110256064A1
(en)
|
2010-04-16 |
2011-10-20 |
Ac Immune, S.A. |
Novel Compounds for the Treatment of Diseases Associated with Amyloid or Amyloid-like Proteins
|
|
WO2011136754A1
(en)
|
2010-04-26 |
2011-11-03 |
Mahmut Bilgic |
A medicament developed for the treatment of respiratory diseases
|
|
CN103347500A
(zh)
*
|
2010-08-12 |
2013-10-09 |
利发利希奥公司 |
用于治疗tau蛋白病的组合物和方法
|
|
TR201901644T4
(tr)
|
2010-09-30 |
2019-02-21 |
Chiesi Farm Spa |
İnhalasyon için kuru toz formülasyonlarında magnesyum stearat. kullanımı.
|
|
US20120121656A1
(en)
|
2010-11-15 |
2012-05-17 |
Revalesio Corporation |
Methods and compositions for protecting against neurotoxicity of a neurotoxic agent, and improving motor coordination associated with a neurodegenerative condition or disease
|
|
CA2827027C
(en)
|
2011-02-11 |
2019-06-04 |
Wista Laboratories Ltd. |
Phenothiazine diaminium salts and their use
|
|
BR112014024287A2
(pt)
|
2012-03-27 |
2018-05-08 |
Duke University |
composições e métodos para a prevenção e tratamento do derrame vascular induzido por mastócitos
|
|
KR20150011807A
(ko)
|
2012-05-25 |
2015-02-02 |
질리어, 인크. |
자일리톨계 항-점액성 조성물과 관련 방법 및 조성물
|
|
US9655977B2
(en)
*
|
2012-08-31 |
2017-05-23 |
The General Hospital Corporation |
Biotin complexes for treatment and diagnosis of alzheimer's disease
|
|
RU2627591C2
(ru)
|
2012-10-23 |
2017-08-09 |
Тейдзин Фарма Лимитед |
Терапевтический или профилактический агент для синдрома распада опухоли
|
|
US10058530B2
(en)
|
2012-10-25 |
2018-08-28 |
The General Hospital Corporation |
Combination therapies for the treatment of Alzheimer's disease and related disorders
|
|
CN104869993B
(zh)
*
|
2012-10-25 |
2019-01-15 |
通用医疗公司 |
治疗阿尔茨海默病及相关疾病的组合疗法
|
|
CA2913235C
(en)
*
|
2013-05-23 |
2021-07-13 |
Aztherapies, Inc. |
Methods for delivering cromolyn
|
|
US10525005B2
(en)
|
2013-05-23 |
2020-01-07 |
The General Hospital Corporation |
Cromolyn compositions and methods thereof
|
|
CN104288168B
(zh)
*
|
2013-07-17 |
2017-08-18 |
吉林敖东洮南药业股份有限公司 |
延龄草苷在制备用于治疗和/或预防小胶质细胞介导的疾病的药物中的用途
|
|
HK1223541A1
(zh)
|
2013-10-22 |
2017-08-04 |
The General Hospital Corporation |
色甘酸衍生物以及成像和治疗的相关方法
|
|
DK3104853T3
(da)
|
2014-02-10 |
2019-12-09 |
Respivant Sciences Gmbh |
Behandling med mastcellestabilisatorer til systemiske forstyrrelser
|
|
WO2015120392A1
(en)
*
|
2014-02-10 |
2015-08-13 |
Patara Pharma, LLC |
Mast cell stabilizers for lung disease treatment
|
|
CN107735077A
(zh)
|
2014-11-21 |
2018-02-23 |
拜尔哈文制药股份有限公司 |
利鲁唑的舌下给药
|
|
US11723864B2
(en)
|
2015-05-29 |
2023-08-15 |
The Texas A&M University System |
Antimicrobial and anti-inflammatory compositions
|
|
US10265296B2
(en)
|
2015-08-07 |
2019-04-23 |
Respivant Sciences Gmbh |
Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
|
|
EP3331522A1
(en)
|
2015-08-07 |
2018-06-13 |
Patara Pharma LLC |
Methods for the treatment of mast cell related disorders with mast cell stabilizers
|
|
US20180311236A1
(en)
*
|
2015-10-28 |
2018-11-01 |
Ab Science |
Use of masitinib and other mast cell inhibitors for treatment of parkinson's disease
|
|
KR20180081807A
(ko)
|
2015-11-19 |
2018-07-17 |
아즈테라피즈 인코포레이티드 |
알츠하이머 질환 및 관련 장애의 치료 방법
|
|
JP2018538273A
(ja)
*
|
2015-11-23 |
2018-12-27 |
エーゼットセラピーズ， インコーポレイテッド |
虚血性脳卒中を処置するための組成物および方法
|
|
US10092564B2
(en)
*
|
2016-03-25 |
2018-10-09 |
Ab Science |
Use of masitinib for treatment of an amyotrophic lateral sclerosis patient subpopulation
|
|
JP2019524865A
(ja)
|
2016-08-31 |
2019-09-05 |
ザ ジェネラル ホスピタル コーポレイション |
神経変性疾患と関連する神経炎症におけるマクロファージ／ミクログリア
|
|
CA3036230A1
(en)
|
2016-09-08 |
2018-03-15 |
Emergo Therapeutics, Inc. |
Mast cell stabilizers for treatment of hypercytokinemia and viral infection
|
|
KR20210070232A
(ko)
|
2017-07-20 |
2021-06-14 |
아즈테라피즈 인코포레이티드 |
크로몰린 나트륨 및 이부프로펜의 분말화된 제형
|
|
CN108164409B
(zh)
|
2018-01-24 |
2021-06-18 |
温州医科大学 |
一种2-亚苄基-1-茚酮类似物及应用
|
|
WO2019199776A1
(en)
|
2018-04-09 |
2019-10-17 |
The General Hospital Corporation |
Combination therapies for the treatment of amyotropic lateral sclerosis and related disorders
|
|
CN108403708B
(zh)
|
2018-05-22 |
2019-06-14 |
滨州医学院 |
秦皮苷在制备预防或治疗急性呼吸窘迫综合征药物中的应用
|
|
JP2021529771A
(ja)
|
2018-07-02 |
2021-11-04 |
ザ ジェネラル ホスピタル コーポレイション |
クロモリンナトリウムおよびα−ラクトースの粉末製剤
|
|
US20220218652A1
(en)
|
2018-09-05 |
2022-07-14 |
The General Hospital Corporation |
Methods of treating cytokine release syndrome
|
|
US12383528B2
(en)
|
2018-12-10 |
2025-08-12 |
The General Hospital Corporation |
Cromolyn esters and uses thereof
|
|
IL297023A
(en)
|
2020-04-06 |
2022-12-01 |
Massachusetts Gen Hospital |
Methods for treating inflammatory conditions caused by the corona virus
|
|
US20230226017A1
(en)
|
2020-06-04 |
2023-07-20 |
The General Hospital Corporation |
Methods of treating a coronavirus infection
|
|
WO2022146914A1
(en)
|
2020-12-28 |
2022-07-07 |
The General Hospital Corporation |
Cromolyn derivatives and uses thereof
|